✦ LIBER ✦

Lack of a docking mechanism for neurotransmitter release in the aganglionic segment of bowel in patients with Hirschsprung's disease

✍ Scribed by Y. Kakita; K. Ohshiro; P. Puri; H. Kobayashi; D. S. O'Briain

Publisher: Springer-Verlag
Year: 1998
Tongue: English
Weight: 276 KB
Volume: 13
Category: Article
ISSN: 0179-0358
DOI: 10.1007/s003830050408

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of double-balloon enteroscopy in the

Use of double-balloon enteroscopy in the management of patients with Crohn’s disease: feasibility and diagnostic yield in a high-volume centre for inflammatory bowel disease

✍ Gianpiero Manes; Venerina Imbesi; Sandro Ardizzone; Andrea Cassinotti; Stefano P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 185 KB

Pure ileal Crohn's disease without colon

Pure ileal Crohn's disease without colonic involvement after a long ileo-colonic anastomosis (Lester Martin Procedure) for Hirschsprung's disease: An argument favoring a specific sensitivity of the ileum in a subset of patients with Crohn's disease

✍ Xavier Dray; Harry Sokol; Kouroche Vahedi; Anne Lavergne-Slove; Philippe Marteau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

Misclassification of dysplasia in patien

Misclassification of dysplasia in patients with inflammatory bowel disease: Consequences for progression rates to advanced neoplasia

✍ Fiona D.M. van Schaik; Fiebo J.W. ten Kate; G. Johan A. Offerhaus; Marguerite E. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB 👁 1 views

## Background: The natural behavior of flat low-grade (LGD) and indefinite dysplasia (IND) in patients with inflammatory bowel disease (IBD) remains uncertain and seems to be dependent on the interpretation of the pathologist. We studied the progression rate of flat LGD and IND to advanced neoplas

Cognitive function and risks of cardiova

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

✍ B. E. de Galan; S. Zoungas; J. Chalmers; C. Anderson; C. Dufouil; A. Pillai; M. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 169 KB